Parent Company Only Condensed Financial Information, Condensed Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities [Abstract]
Net income (loss)	$ 5,636	$ (4,050)
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]
Change in other assets	(995)	908
Change in accrued expenses and other liabilities	(461)	3,330
Net cash provided by operating activities	6,324	624
Cash flows from investing activities [Abstract]
Net cash (used in) provided by investing activities	(323,959)	24,965
Cash flows from financing activities [Abstract]
Proceeds from sale of stock	0	30,837
Issuance of preferred stock	150,000	0
Increase in unreleased ESOP shares	(500)	0
Net cash provided by financing activities	102,220	109,822
Net change in cash and cash equivalents	(215,415)	135,411
Cash and cash equivalents at beginning of the period	231,520	96,109
Cash and cash equivalents at end of the period	16,105	231,520
Broadway Financial Corporation [Member]
Cash flows from operating activities [Abstract]
Net income (loss)	5,636	(4,050)
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]
Equity in undistributed subsidiary loss (income)	(6,340)	2,440
Change in other assets	1,196	(1,333)
Change in accrued expenses and other liabilities	(348)	504
Net cash provided by operating activities	144	(2,439)
Cash flows from investing activities [Abstract]
Capital distribution to bank subsidiary	(75,000)	(20,000)
Dividends from bank subsidiary	0	700
Net cash (used in) provided by investing activities	(75,000)	(19,300)
Cash flows from financing activities [Abstract]
Proceeds from sale of stock	0	30,837
Issuance of preferred stock	150,000	0
Repayments of borrowings	0	(3,315)
Equity in CFBanc Corp on date of purchase	0	3,330
Increase in unreleased ESOP shares	(500)	0
Proceeds from repayment of ESOP loan	66	66
Net cash provided by financing activities	149,566	30,918
Net change in cash and cash equivalents	74,710	9,179
Cash and cash equivalents at beginning of the period	9,305	126
Cash and cash equivalents at end of the period	84,015	$ 9,305
Non-cash financing activities for exchange of preferred stock for common stock	$ 3,000